FIELD: medicine.
SUBSTANCE: patients' blood serum is examined for the pre-therapeutic mean molecule spectrum. If a mean molecule fraction described as an optical absorption E at wave length 230 nm is below 0.118 standard units, and a nuclear-peptide index described as a relation of the optical absorption E at wave length 230 nm to the optical absorption E at wave length 254 nm is below 0.8, the severe clinical course of epilepsy is predicted.
EFFECT: using the declared method enables the more accurate prediction of the clinical course of epilepsy.
1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF CLINICAL COURSE OF BORDER PSYCHIC DISORDERS | 2011 |
|
RU2455646C1 |
| METHOD OF EFFICIENCY FORECAST FOR RESIDUAL SHIZOPHRENIA TREATMENT BY ATYPICAL NEUROLEPTIC QUETIAPINE | 2007 |
|
RU2349918C1 |
| METHOD FOR PREDICTING THE UNFAVORABLE COURSE OF EPILEPSY IN CHILDREN IN THE FIRST YEAR OF LIFE | 2022 |
|
RU2787512C1 |
| METHOD FOR DIAGNOSING GENERALIZED CONVULSION PAROXYSMS | 1996 |
|
RU2115931C1 |
| METHOD FOR PREDICTING THE SEVERITY OF JUVENILE MYOCLONUS EPILEPSY IN CHILDREN | 2006 |
|
RU2310377C1 |
| METHOD TO TREAT EPILEPSY | 1994 |
|
RU2071312C1 |
| METHOD FOR MEDICINAL TREATMENT OF PSYCHO-VOCAL DISORDER IN CASE OF JUVENILE MYOCLONAL EPILEPSY IN CHILDREN | 2006 |
|
RU2314021C1 |
| METHOD OF PREVENTING GESTATIONAL COMPLICATIONS IN PREGNANT WOMEN WITH EPILEPSY | 2017 |
|
RU2657772C1 |
| METHOD FOR EVALUATING EPILEPSY PHARMACOTHERAPY EFFECTIVENESS | 2000 |
|
RU2164688C1 |
| METHOD OF EPILEPSIA DIAGNOSIS | 0 |
|
SU1439505A2 |
